Literature DB >> 3107549

A phospholipase A2 isoenzyme provokes lipoxin B formation from endogenous sources of arachidonic acid in porcine leukocytes.

B K Lam, C N Serhan, B Samuelsson, P Y Wong.   

Abstract

Porcine leukocytes incubated with an isoenzyme of phospholipase A2 (PLA2) (isolated from snake venom) produced several trihydroxytetraene- containing compounds which were derived from endogenous sources of arachidonic acid. The formation of these compounds was dose-dependent with an EC50 of approximately 1.25 X 10(-8) M. At this concentration of the isoenzyme and time of exposure the cells remained viable as determined by the exclusion of trypan blue. The compounds were purified by HPLC and their identities were determined by physical criteria which included U.V. spectrometry, GC/MS and by comparison with both synthetic and authentic materials. The biologically derived compounds proved to be lipoxin B (5S, 14R, 15S-trihydroxy-6, 10, 12-trans-8-cis-eicosatetraenoic acid) and its two structural isomers (8-trans-LXB and 14S-8-trans-LXB). Of interest, only small amounts of lipoxin A and its isomers were found in these incubations. Results of the present study indicate that porcine leukocytes can generate lipoxin B and its isomers from endogenous sources of arachidonic acid. Moreover, they suggest that certain PLA2 isoenzymes may initiate the formation of lipoxins and related compounds.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3107549     DOI: 10.1016/s0006-291x(87)80484-9

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  2 in total

Review 1.  Lipoxins: eicosanoids carrying intra- and intercellular messages.

Authors:  C N Serhan
Journal:  J Bioenerg Biomembr       Date:  1991-02       Impact factor: 2.945

2.  Lipoxin formation during human neutrophil-platelet interactions. Evidence for the transformation of leukotriene A4 by platelet 12-lipoxygenase in vitro.

Authors:  C N Serhan; K A Sheppard
Journal:  J Clin Invest       Date:  1990-03       Impact factor: 14.808

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.